As the KMT2A rearrangement was an unfavorable prognostic factor (5, 6) in ALL, further investigation of the potential interplay of aberrant GATA2 transcription and KMT2A fusions might shed new light on the molecular basis of this subtype of B-ALL. The gene discussed is GATA2; the disease is acute lymphoblastic leukemia.